Moebius Syndrome Market Research Report - Global Forecast till 2027

Moebius Syndrome Market Research Information: By Type (Group I, Group Ii, Group Iii, Group Iv), Treatment (Surgery, Parotidectomy, Temporalis Transfer, Speech & Occupational Therapy, Prosthesis, Splints, and Braces), End User – Global Forecast till 2027

ID: MRFR/Pharma/3964-HCR | | Region : Global

Market Scenario


Moebius syndrome is a rare neurological condition characterized by paralysis of multiple cranial nerves, and most often the abducens and facial nerves. Signs and symptoms of Moebius include paralysis of the facial muscles, swallowing and choking problems, crossed eyes, bone abnormalities in the hands, speech difficulties, high or cleft palate, excessive drooling, and various others. As per the National Center for Advancing Translational Sciences, abnormality of the voice, masklike facies, Bell's palsy, feeding difficulties in infancy, and open mouth commonly occur in 80%-99% cases of Moebius syndrome.


According to the U.S National Library of Medicine, Moebius syndrome affects 1 in 50,000 to 1 in 500,000 newborns. It also mentions that the affected individuals lack facial expressions i.e. they cannot smile, or raise their eyebrows.


It is noted that growing public awareness and technological advancements are the key factors driving the Moebius syndrome market. On the technology front, various surgical options have been used for an effective management of symptoms associated with Moebius syndrome such as facial nerve grafting, facial nerve decompression, transposition of the temporalis muscle, and others.


Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the global Moebius syndrome market. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.


Despite these drivers, there are some issues associated with Moebius syndrome market. The complications associated with the available treatments, infections, and injuries caused by surgical devices, and poor healthcare system in low and middle-income countries, may hinder the growth of the market.


It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.


Key Players


Some of key the players in the global moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc., and others.


Intended Audience



  • Medical Device Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities


Research Methodology Moebius Syndrome Market


Sources: Annual reports, Press release, White paper, and Company presentation


Segmentation


The global Moebius syndrome market is segmented on the basis of type, treatment, and end user.


On the basis of the type, the market is classified as Group I, Group II, Group III, and Group IV.


On the basis of the treatment, the market is classified as surgery, temporalis transfer, parotidectomy, physical therapy, occupational therapy, speech therapy, splints, prosthesis, braces, and others. The surgery segment is further classified into eyelid surgery, ponseti method, hand surgery, tracheotomy, and others.


On the basis of the end user, the market is segmented into medical device companies, hospitals & clinics, academic & research institutes, and others.


Regional Analysis


The Americas dominate the Moebius syndrome market owing to the rising awareness among the population coupled with and high healthcare expenditure.


Europe holds the second position in the Moebius syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.


Asia Pacific is the fastest growing Moebius syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.


The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Moebius Syndrome Market, by Type

6.1 Introduction

6.2 Group I

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Group II

6.3.1 Market Estimates & Forecast, 2020 – 2027

6.4 Group III

6.4.1 Market Estimates & Forecast, 2020 – 2027

6.5 Group IV

6.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Moebius Syndrome Market, by Type of Treatment

7.1 Introduction

7.2 Surgery

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Temporalis Transfer

7.3.1 Market Estimates & Forecast, 2020 – 2027

7.4 Parotidectomy

7.4.1 Market Estimates & Forecast, 2020 – 2027

7.5 Physical Therapy

7.5.1 Market Estimates & Forecast, 2020 – 2027

7.6 Occupational Therapy

7.6.1 Market Estimates & Forecast, 2020 – 2027

7.7 Speech Therapy

7.7.1 Market Estimates & Forecast, 2020 – 2027

7.8 Splints

7.8.1 Market Estimates & Forecast, 2020 – 2027

7.9 Prosthesis

7.9.1 Market Estimates & Forecast, 2020 – 2027

7.10 Braces

7.10.1 Market Estimates & Forecast, 2020 – 2027

7.11 Others

7.11.1 Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Moebius Syndrome Market, by End User

8.1 Introduction

8.2 Medical Device Companies

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Hospitals & Clinics

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Academic & Research Institutes

8.4.1 Market Estimates & Forecast, 2020 – 2027

8.5 Others

8.5.1 Market Estimates & Forecast, 2020 – 2027

Chapter 9. Global Moebius Syndrome Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Alcon Laboratories, Inc

11.1.1 Company Overview

11.1.2 Type of Causative Agents Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 All Vascular, Pty Ltd.

11.2.1 Company Overview

11.2.2 Type of Causative Agents Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Aspen Surgical Products, Inc.

11.3.1 Company Overview

11.3.2 Type of Causative Agents Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 B. Braun Melsungen AG

11.4.1 Company Overview

11.4.2 Type of Causative Agents/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Boston Scientific Corporation

11.5.1 Company Overview

11.5.2 Type of Causative Agents Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 BECTON, DICKINSON AND COMPANY

11.6.1 Company Overview

11.6.2 Type of Causative Agents Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Johnson & Johnson Services, Inc.

11.7.1 Overview

11.7.2 Type of Causative Agents Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Moebius Syndrome Industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Moebius Syndrome Industry Synopsis, 2020 – 2027

Table 2 Moebius Syndrome Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Moebius Syndrome Market by Region, 2020 – 2027, (USD Million)

Table 4 Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 5 Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 6 Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 7 North America Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 8 North America Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 9 North America Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 10 US Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 11 US Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 12 US Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 13 Canada Moebius Syndrome market by Type, 2020 – 2027, (USD Million)

Table 14 Canada Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 15 Canada Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)

Table 16 South America Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 17 South America Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 18 South America Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 19 Europe Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 20 Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 21 Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 23 Western Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 24 Western Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Moebius Syndrome market by Type, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Moebius Syndrome Market by End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)

Table 31 The Middle East & Africa Moebius Syndrome Market by Type, 2020 – 2027, (USD Million)

Table 32 The Middle East & Africa Moebius Syndrome Market by Type of Treatment, 2020 – 2027, (USD Million)

Table 33 The Middle East & Africa Moebius Syndrome market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Moebius Syndrome Market

Figure 3 Segmentation Market Dynamics for Moebius Syndrome Market

Figure 4 Global Moebius Syndrome market Share, by Type 2020

Figure 5 Global Moebius Syndrome market Share, by Type of Treatment 2020

Figure 6 Global Moebius Syndrome market Share, by End Users, 2020

Figure 7 Global Moebius Syndrome market Share, by Region, 2020

Figure 8 North America Moebius Syndrome market Share, by Country, 2020

Figure 9 Europe Moebius Syndrome market Share, by Country, 2020

Figure 10 Asia Pacific Moebius Syndrome market Share, by Country, 2020

Figure 11 Middle East & Africa Moebius Syndrome market Share, by Country, 2020

Figure 12 Global Moebius Syndrome market: Company Share Analysis, 2020 (%)

Figure 13 Alcon Laboratories, Inc: Key Financials

Figure 14 Alcon Laboratories, Inc: Segmental Revenue

Figure 15 Alcon Laboratories, Inc: Geographical Revenue

Figure 16 All Vascular, Pty Ltd.: Key Financials

Figure 17 All Vascular, Pty Ltd.: Segmental Revenue

Figure 18 All Vascular, Pty Ltd.: Geographical Revenue

Figure 19 Aspen Surgical Products, Inc.: Key Financials

Figure 20 Aspen Surgical Products, Inc.: Segmental Revenue

Figure 21 Aspen Surgical Products, Inc.: Geographical Revenue

Figure 22 B. Braun Melsungen AG : Key Financials

Figure 23 B. Braun Melsungen AG : Segmental Revenue

Figure 24 B. Braun Melsungen AG : Geographical Revenue

Figure 25 Boston Scientific Corporation: Key Financials

Figure 26 Boston Scientific Corporation: Segmental Revenue

Figure 27 Boston Scientific Corporation Geographical Revenue

Figure 28 BECTON, DICKINSON AND COMPANY: Key Financials

Figure 29 BECTON, DICKINSON AND COMPANY: Segmental Revenue

Figure 30 BECTON, DICKINSON AND COMPANY: Geographical Revenue

Figure 31 Johnson & Johnson Services, Inc.: Key Financials

Figure 32 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 33 Johnson & Johnson Services, Inc.: Geographical Revenu